Document is current
Any future updates will be listed below
-
Authors
Hunt, Allison L.
Randall, Jamie
Mansukhani, Mahesh M.
Nyberg, Kara
Nutcharoen, Aratara
Davis, Justin
Corgiat, Brian
Mueller, Claudius
Melvin, Savannah
Sharma, Meenakshi
Johnston, Laura
Swain, Whitney
Abulez, Tamara
Bateman, Nicholas W.
Maxwell, G. Larry
Deeken, John
Benyounes, Amin
Petricoin, Emanuel F.
Cannon, Timothy L.
Conrads, Thomas P.
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 7 March 2025
First Online: 15 April 2025
Competing interests
: T.P.C. is a ThermoFisher Scientific, Inc. SAB member and receives research funding from AbbVie. E.F.P. is a SAB member and consultant to Ignite Proteomics, Inc., and receives research funding from Genentech, Pfizer, Mirati, Springworks Therapeutics, Deciphera, AbbVie, and is a co-inventor of the RPPA Technology described herein, and related HER2 biomarker patents and receives royalties on the related license agreements. K.N. is an independent consultant and receives funding from Catalyst Medical Media, Clinical Care Options, Global Healthcare Marketing & Communications, Health and Wellness Partners, Interactive Forums, MphaR, and PharMecha. J.D., B.C., and C.M. are full-time employees of Ignite Proteomics, Inc.
